WASHINGTON — Health industry leaders pushed back on President Trump’s executive order on vaccines this week — including those he may need to rely on for his agenda.
On Monday, Trump signed an order that sought to unilaterally change the federal government’s approach to vaccinating children: recommending fewer shots, spreading them over longer periods, and doing so without evidence to back up the changes.
Trump was particularly interested in breaking up the vaccine that protects against measles, mumps, and rubella into three separate shots, saying — against all current evidence — that the combination shot could be lethal. (Trump later said he had no evidence for the claim; his health officials have repeatedly said they recommend the shot.)
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
